What is CorMedix's finished goods?

CorMedix (CRMD) reported finished goods of $15.29M in Q1 2026.

How has CorMedix's finished goods changed year-over-year?

CorMedix's finished goods increased by 629.8% year-over-year, from $2.09M to $15.29M.

What is the long-term trend for CorMedix's finished goods?

Over 3 years (2020 to 2025), CorMedix's finished goods has grown at a 256.5% compound annual growth rate (CAGR), from $317.73K to $14.39M.

What does finished goods mean?

Completed products ready for sale, valued at the lower of cost or net realizable value.

CorMedix CRMD Finished goods

Finished goods at other companies

Merck & Co.MRK

$2.21B+3.9%

ITG

Integer HoldingsITGR

$23.36M+44.2%

IAR

Integra LifeSciencesIART

$253.15M+12.3%

Emergent BiosolutionsEBS

$133M+11.8%

ICU MedicalICUI

$289.36M+9.9%

Mirum Pharmaceuticals, Inc.MIRM

$3.42M-4.4%

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's finished goods?: CorMedix (CRMD) reported finished goods of $15.29M in Q1 2026.
How has CorMedix's finished goods changed year-over-year?: CorMedix's finished goods increased by 629.8% year-over-year, from $2.09M to $15.29M.
What is the long-term trend for CorMedix's finished goods?: Over 3 years (2020 to 2025), CorMedix's finished goods has grown at a 256.5% compound annual growth rate (CAGR), from $317.73K to $14.39M.
What does finished goods mean?: Completed products ready for sale, valued at the lower of cost or net realizable value.